HomeScienceEbola Response: Celebrating the Strength of African Science

Ebola Response: Celebrating the Strength of African Science

The Vital Role of African Science in Combating the Ebola Outbreak

Rapid Detection: A Triumph of Local Science

In May 2026, reports of an unusual cluster of severe illnesses reached health authorities in Ituri Province, Democratic Republic of Congo (DRC). The Institut National de Recherche Biomédicale (INRB) in Kinshasa swiftly stepped up to the challenge. Researchers analyzed blood samples to confirm the pathogen responsible for this alarming outbreak, diagnosing it as Bundibugyo ebolavirus—a rare strain previously responsible for only two outbreaks in history, in Uganda (2007) and Isiro, DRC (2012).

This rapid identification marked not just a success but underscored the importance of local expertise in managing health crises. While such behind-the-scenes efforts may not capture headlines, they are the backbone upon which every other response action relies.

Lessons from the Past: The Evolution of Response Capacity

A decade ago, Africa’s battle against Ebola was often framed through a lens of what was lacking: inadequate laboratories, limited genomic capabilities, and insufficient infrastructure to conduct clinical trials amid outbreaks.

The devastating Ebola epidemic in West Africa from 2014 to 2016 was a pivotal moment. It revealed substantial gaps but simultaneously spurred a significant investment wave in improving the continent’s health infrastructure. As a result, African countries are better equipped than ever to tackle emerging health threats, with the establishment of institutions like the Africa Centres for Disease Control and Prevention (Africa CDC) emerging from the ashes of that crisis.

Africa CDC: Central to Disease Response

The Africa CDC has become an integral part of the framework for disease detection and response across the continent. Founded in 2016, this institution plays a critical role in enhancing national laboratory systems, training epidemiologists, and operationalizing genomic sequencing networks in multiple countries.

When the World Health Organization (WHO) declared the Bundibugyo outbreak a Public Health Emergency of International Concern on May 17, Africa CDC immediately mobilized its rapid response framework. The very next day, it labeled the outbreak a Public Health Emergency of Continental Security, showcasing a coordinated response that spans borders and disciplines.

A Collaborative Response

This outbreak has seen collaboration across the continent, with researchers from various institutions, including Stellenbosch University, joining the scientific response. At the CelebrateLAB West Africa Conference in late May, Africa CDC initiated a therapeutic repurposing initiative aimed at accelerating African-led research into diagnostics and treatments for future outbreaks.

The presence and central role of African scientists in these endeavors highlight a marked shift from historical narratives that often depicted the continent as a passive recipient of foreign aid in health crises. African researchers are now on the front lines, driving innovation and leading response efforts.

The Necessity of Sustained Investment

However, urgency alone will not sustain this momentum. What is needed is predictable, long-term investment in the systems that enable swift responses to health crises. This includes developing well-equipped laboratories, genomic sequencing capabilities, and robust data infrastructures along with cultivating a workforce of trained professionals.

Investment from philanthropies like the Gates Foundation, alongside partnerships with the WHO, the European Union, and various bilateral entities, has significantly bolstered outbreak preparedness and response capacities. Such investments, aligned with national priorities, not only bolster local institutions but also facilitate proactive measures that can prevent outbreaks from escalating.

The Invisible Value of Preparedness

The importance of preparedness often goes unnoticed until a crisis arises. Yet, the fact remains that diseases know no borders; an outbreak in one locality can quickly escalate into a national or global crisis. For this reason, investing in capacities for early detection and rapid response is not merely an African priority—it is a global obligation.

As we saw in June, commitments from donors far exceeded initial expectations, amassing totals of $910 million against a target of $518 million. However, the fundamental need for a robust preparedness infrastructure remains underfunded.

Policies Shaping the Future

During the 79th World Health Assembly, a shared commitment to reforming the global health architecture was underscored. Several African nations received recognition for their public health achievements, marking a significant acknowledgment of the continent’s growing role in global health.

Investments in institutional frameworks, regulatory systems, and clinical trial platforms are equally critical. These factors not only help future-proof regions against health threats but also enable African nations to control their health agendas rather than merely responding to externally dictated initiatives.

The Role of Local Institutions

Institutions like the African Population and Health Research Center (APHRC) emphasize the importance of local evidence generation. Working on over 100 projects in 44 countries, APHRC collaborates with African researchers to produce data that informs both national and regional health policies.

Their initiatives, including the Countdown to 2030, focus on ensuring that the specific health needs of women, children, and adolescents are addressed, thereby empowering local communities through informed decision-making.

Building a Sovereign Health Strategy

The Consortium for Africa Cross-Border Evidence and Policy Sovereignty aims to enable African countries to set their research agendas in matters of cross-border health security. This approach focuses on context and culture, ensuring that the questions asked and methods employed are relevant to local realities.

While progress has been made, it is evident that sustained investment in African scientific capacity is paramount. The recent Ebola outbreak is an indication of the advancements made, but also a reminder that the journey is ongoing.

By reinforcing the systems that allow for rapid response and effective management of health crises, the global health community, including African nations themselves, can secure a future where outbreaks are contained swiftly and efficiently. The ambition set forth in recent global health gatherings must be coupled with concrete investments in African institutions and researchers.